er positive breast cancer icd 10

Release time ：Dec-18,2024

Estrogen receptor-positive breast cancer (ICD-10 coded) is a prevalent form of breast cancer that tends to respond well to endocrine therapy, thus offering a relatively favorable prognosis when detected and treated early.

The presence of estrogen receptors on the surface of tumor cells in estrogen receptor-positive breast cancer suggests that tumor growth may be influenced by estrogen levels within the body. Consequently, treatment strategies for this type of breast cancer are primarily aimed at reducing estrogen levels or blocking the interaction between estrogen and its receptors. Premenopausal women might undergo treatment with ovarian function inhibitors, while postmenopausal women could be prescribed aromatase inhibitors. Furthermore, for patients who are not candidates for surgery or radiotherapy, endocrine therapy can serve as an adjunct to their treatment. It’s important to recognize that while estrogen receptor-positive breast cancer is generally sensitive to endocrine therapy, not all patients will benefit, necessitating a personalized approach to treatment planning.

Patients diagnosed with estrogen receptor-positive breast cancer are advised to maintain healthy dietary and exercise routines in conjunction with their standard treatment. They should aim for a balanced diet, limiting high-fat and high-sugar foods, and increasing their consumption of vegetables and fruits. Engaging in regular physical activity can also enhance overall health and immune function, which can help manage treatment-related side effects more effectively. Lastly, patients should closely monitor their health during treatment, seek immediate medical attention for any discomfort, and adhere to the prescribed treatment regimen under a physician's guidance, avoiding any self-initiated changes to their medication or treatment plan.